Clinical Trial Update: A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the relative bioavailability and safety of SHR-3167 injection in diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SHR-3167 Injection (SHR-3167)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Diabetes Mellitus | Phase 1 | Status: NOT_YET_RECRUITING